Skip to main content

Surgical skin preparation

SSI prevention: Stronger together 

You're on the front lines in the fight against healthcare-acquired infections (HAIs), and as your partner, we're here to support you with science-based solutions and a holistic approach to risk reduction. Collaborating with clinical experts, we provide resources to combat surgical site infections (SSIs). 

We know that: 

80%

SSIs from S. aureus

80% of SSIs from S. aureus come from the patient’s own nasal flora,1-3 causing up to $60k in additional hospital charges due to SSIs4

300k

U.S. patients

Up to 300,000 U.S. patients yearly are affected by SSIs5

5%

annual U.S. surgeries

Up to 5% of the 27 million annual U.S. surgeries will lead to SSIs6

8.2M

people at risk for SSIs

8.2 million people are at risk for SSIs7, which potentially increases the length of hospital stays and puts your patients at risk

We aim to reduce microbial presence, safeguarding your patients from potential skin or incision-related infections. 

3M Skin and Nasal Antiseptic

Minimize the risk of SSIs by reducing bacterial presence on the patient's skin with 3M™ Skin and Nasal Antiseptic (Povidone-Iodone Solution 5% w/w [0.5% available iodine] USP) Patient Preoperative Skin Preparation.

  • 80% of SSIs from S. aureus come from the patient’s own nasal flora1-3, making it a significant risk factor for developing SSI
  • Skin and Nasal Antiseptic helps reduce SSI when part of a comprehensive preoperative protocol

Follow guidelines and practices by leading organizations to help decrease the risk of SSIs.

Explore solutions
Skin and Nasal Antiseptic Bottle and Applicators, white background, product photo, cmyk, tiff, 70-2010-8268-5, 70-2010-8271-9, 70-2010-8272-7, 70-2010-8274-3, 70-2010-8275-0, 70-2010-8277-6, 70-2010-8278-4, 70-2010-8380-8, 70-2010-8378-2, 70-2010-8379-0, 70-2010-8375-8, 70-2010-8374-1, 70-2010-8399-8

Soluprep S Sterile Antiseptic solution

Quickly and effectively minimize bacterial presence with 3M™ SoluPrep™ S Sterile Antiseptic Solution chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v) Patient Preoperative Skin Preparation.

  • Over 96 hours of broad-spectrum, antimicrobial persistence under simulated surgical conditions* makes it the trusted skin preparation solution.  
  • 52% reduction in drape lift through enhanced, incise drape adherence⁸ 
  • Matches the leading competitor's active ingredients.**⁸  
  • 60% more coverage area when using a 26mL applicator.***⁹

SoluPrep S Sterile Antiseptic Solution provides added benefit for preparing patients' skin before surgery, providing safety and protection against potential skin infections.


*Study was performed under simulated surgical conditions. 
**Compared to skin prepped with ChloraPrep® with 3MTM IobanTM 2 Antimicrobial Incise Drapes in a simulated knee surgery model, 2019.
***Compared to ChloraPrep® Surgical Prep, 2021.

Explore solutions
3M™ SoluPrep™ S Sterile Antiseptic Solution, 2% CHG/70% IPA, 67134, Clear, 10.5 mL

Contact a Solventum representative

We're here to help! Our team of representatives can provide you with information and resources to help you. Submit the form below to speak with a Solventum representative to learn more about your options.

Looking for customer support? Visit the customer support page.

Fields marked with an * are required.

 

Solventum will use the information to respond to your request in accordance with our Privacy Policy. 

References

 

  1. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mup. to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871-1877. 
  2. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, deBaere GAJ, Kluytmans JAJW. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000;21:319-323. 
  3. Kluytmans JAJW, Mouton JW, Ijzerman EPF, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis. 1995;171:216-219. 
  4. Anderson DJ, Kaye KS, Chen LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE. 2009;4:e8305. 
  5. Anderson DJ, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemol. 2014;35(6): 605-627. 
  6. Darouiche, Rabih. “Surgical Site Infections.” Infectious Disease Advisor, 20 Jan. 2019, https://www.infectiousdiseaseadvisor.com/home/decision-support-in-medicine/hospital-infection-control/surgical-site-infections/. 
  7. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198-1208. 
  8. Olson L, Morse D, Paulson J, Bernatchez S. Evaluation of Incise Drape Lift Using 2% Chlorhexidine Gluconate/ 70% Isopropyl Alcohol Preoperative Skin Preparations in a Human Volunteer Knee Model. 2022;15:24-28. 
  9. 3M Data on File. EM-05-014815.